MoneyWorks4Me

Aarti Pharmalabs informs about credit rating

17 Jul 2025 Evaluate

Aarti Pharmalabs has informed that, CRISIL Ratings has upgraded the credit ratings for long-term bank loan facilities of the Company vide its communication dated 17th July, 2025. The company has enclosed the details of the ratings on the bank facilities. A copy of the report from CRISIL Ratings is also enclosed. The above information will also be available on the website of the Company at https://www.aartipharmalabs.com/credit-ratings.

The above information is a part of company’s filings submitted to BSE. 


Aarti Pharmalabs Share Price

870.85 -15.60 (-1.76%)
13-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.85
Dr. Reddys Labs. 1206.00
Cipla 1461.00
Lupin 2261.00
Zydus Lifesciences 1173.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: